Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA SNS-032 CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.12 7e-05
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.13 8e-05
mRNA rigosertib CTRPv2 pan-cancer AAC 0.13 9e-05
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.13 9e-05
Download CSV